|
|
||||||||

*
Departments of Immunology, Medicine, and Molecular and Medical Genetics, University of Toronto, The Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; and
Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892.
The selection events shaping T cell development in the thymus represent the outcome of TCR-driven intracellular signaling cascades evoked by Ag receptor interaction with cognate ligand. In view of data indicating TCR-evoked thymocyte proliferation to be negatively modulated by the SHP-1 tyrosine phosphatase, a potential role for SHP-1 in regulating selection processes was investigated by analysis of T cell development in H-Y TCR transgenic mice rendered SHP-1 deficient by introduction of the viable motheaten mutation or a dominant negative SHP-1-encoding transgene. Characterization of thymocyte and peripheral T cell populations in H-Y TCR-viable motheaten mice revealed TCR-evoked proliferation as well as the positive and negative selection of H-Y-specific thymocytes to be enhanced in these mice, thus implicating SHP-1 in the negative regulation of each of these processes. T cell selection processes were also augmented in H-Y TCR mice carrying a transgene driving lymphoid-restricted expression of a catalytically inert, dominant-negative form of SHP-1. SHP-1-negative effects on thymocyte TCR signaling were not influenced by co-cross-linking of the CD28 costimulatory and/or CTLA-4 inhibitory receptors and appear, accordingly, to be realized independently of these comodulators. These observations indicate that SHP-1 raises the signaling threshold required for both positive and negative selection and reveal the inhibitory effects of SHP-1 on TCR signaling to be cell autonomous. The demonstrated capacity for SHP-1 to inhibit TCR-evoked proliferation and selection indicate SHP-1 modulatory effects on the magnitude of TCR-generated signal to be a key factor in determining the cellular consequences of TCR-ligand interaction.
This article has been cited by other articles:
![]() |
J. G. Sathish, G. Dolton, F. G. LeRoy, and R. J. Matthews Loss of Src Homology Region 2 Domain-Containing Protein Tyrosine Phosphatase-1 Increases CD8+ T Cell-APC Conjugate Formation and Is Associated with Enhanced In Vivo CTL Function J. Immunol., January 1, 2007; 178(1): 330 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Chemnitz, A. R. Lanfranco, I. Braunstein, and J. L. Riley B and T Lymphocyte Attenuator-Mediated Signal Transduction Provides a Potent Inhibitory Signal to Primary Human CD4 T Cells That Can Be Initiated by Multiple Phosphotyrosine Motifs. J. Immunol., June 1, 2006; 176(11): 6603 - 6614. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Carter, G. M. Calabrese, M. Naganuma, and U. Lorenz Deficiency of the Src Homology Region 2 Domain-Containing Phosphatase 1 (SHP-1) Causes Enrichment of CD4+CD25+ Regulatory T Cells J. Immunol., June 1, 2005; 174(11): 6627 - 6638. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. D. Paling and M. J. Welham Tyrosine phosphatase SHP-1 acts at different stages of development to regulate hematopoiesis Blood, June 1, 2005; 105(11): 4290 - 4297. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Chan, C. A. Ackerley, H. Lohi, L. Ianzano, M. A. Cortez, P. Shannon, S. W. Scherer, and B. A. Minassian Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy Hum. Mol. Genet., June 1, 2004; 13(11): 1117 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Deng, A. Minguela, R. Z. Hussain, A. E. Lovett-Racke, C. Radu, E. S. Ward, and M. K. Racke Expression of the Tyrosine Phosphatase Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase 1 Determines T Cell Activation Threshold and Severity of Experimental Autoimmune Encephalomyelitis J. Immunol., May 1, 2002; 168(9): 4511 - 4518. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Sathish, K. G. Johnson, K. J. Fuller, F. G. LeRoy, L. Meyaard, M. J. Sims, and R. J. Matthews Constitutive Association of SHP-1 with Leukocyte-Associated Ig-Like Receptor-1 in Human T Cells J. Immunol., February 1, 2001; 166(3): 1763 - 1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lowin-Kropf, B. Kunz, F. Beermann, and W. Held Impaired Natural Killing of MHC Class I-Deficient Targets by NK Cells Expressing a Catalytically Inactive Form of SHP-1 J. Immunol., August 1, 2000; 165(3): 1314 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pauza, K. M. Smith, H. Neal, C. Reilly, L. L. Lanier, and D. Lo Transgenic Expression of Ly-49A in Thymocytes Alters Repertoire Selection J. Immunol., January 15, 2000; 164(2): 884 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Chiang and B. M. Sefton Specific Dephosphorylation of the Lck Tyrosine Protein Kinase at Tyr-394 by the SHP-1 Protein-tyrosine Phosphatase J. Biol. Chem., June 15, 2001; 276(25): 23173 - 23178. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |